Ozari Health has claimed the top spot in Venture Magazine's 2026 ranking of the most affordable online sources for compounded tirzepatide, with an all-in monthly price of $125 for new patients that bundles the clinician consultation, compounded medication, and shipping into a single published fee with no recurring membership charge.

The ranking methodology evaluated the true first-month cost a new patient would pay—a meaningful benchmark given that competing telehealth platforms frequently separate consultation fees, compound costs, and shipping into distinct line items that can obscure the actual out-of-pocket burden. Ozari's transparent bundled structure positions it as a low-friction entry point for weight-management patients who may be priced out of branded GLP-1 therapies such as Mounjaro and Zepbound, where list prices can exceed $1,000 per month without insurance coverage.

GLP-1 Compounding Landscape

Compounded tirzepatide occupies a legally and commercially complex niche. The FDA permits compounding of tirzepatide when the branded reference drug remains on its shortage list; however, regulatory status is subject to change, and operators in the telehealth and compounding pharmacy space face ongoing compliance scrutiny. For functional nutrition and nutraceutical industry observers, the GLP-1 compounding channel represents a parallel—and rapidly scaling—weight-management pathway that is reshaping consumer expectations around appetite regulation, metabolic support, and adjacent supplement categories including protein and satiety ingredients and gut-health formulations.

Market Implications

The competitive pricing dynamic in compounded GLP-1 access is relevant to the broader better-for-you products ecosystem. As more consumers engage with GLP-1 therapies—compounded or branded—demand is accelerating for complementary functional products that address muscle preservation, micronutrient repletion, and digestive comfort during caloric restriction. Ingredient suppliers and finished-goods formulators are actively developing GLP-1-companion SKUs, and the expansion of low-cost telehealth access points like Ozari could meaningfully widen the addressable consumer base for those adjacencies.

Price competition at the $125-per-month level also underscores the commoditization pressure building across the compounded GLP-1 channel, where differentiation is increasingly shifting toward clinical support quality, adherence programming, and ancillary wellness offerings—areas where functional food and supplement brands have natural integration opportunities.

Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.